NCT03816514

Brief Summary

The primary aim of this study is to evaluate whether pulse oximetry based noninvasive hemoglobin (SpHb) monitoring can reduce the incidence of hemoglobin (Hb) level out of the target range in adult patients undergoing major surgery with the potential risk of bleeding.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 4, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2020

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2020

Completed
Last Updated

December 22, 2020

Status Verified

December 1, 2020

Enrollment Period

1.7 years

First QC Date

December 17, 2018

Last Update Submit

December 20, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of deviation from the target hemoglobin range

    (The number of laboratory samples with the result hemoglobin concentrations were out of the target range)/(Total number of laboratory samples that performed during intra-operative periods)

    Until transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia

Secondary Outcomes (9)

  • The percentage extent of deviation from the target hemoglobin range

    Until transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia

  • Number of Point-of-care (POC) sampling during surgery

    Until transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia

  • Accuracy of the SpHb value

    Until transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia

  • Number of patients who receive intra-operative transfusion

    Until transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia

  • Total volume of intravenous fluids given

    Until transfer to PACU (Post-Anesthesia Care Unit), from the beginning of the induction of anesthesia

  • +4 more secondary outcomes

Study Arms (2)

SpHb monitoring group

EXPERIMENTAL

In SpHb monitoring group, noninvasive, continuous SpHb monitoring will be done using Radical-7 pulse CO-Oximeter. The patients will be managed according to the prespecified protocol based on the SpHb values.

Procedure: SpHb monitoring

Control group

ACTIVE COMPARATOR

In control group, patients will receive conventional management without the SpHb monitoring. In these patients, the information about hemoglobin concentration of the patients will be obtained from hemoglobin measurement analyzed by point-of-care (POC) equipment, as usual standard care.

Procedure: Conventional management

Interventions

Noninvasive, continuous pulse oximetry-based hemoglobin (SpHb) monitoring

SpHb monitoring group

Conventional management without SpHb monitoring

Control group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with ASA physical status class I, II, III, who scheduled to undergo elective non-cardiac major surgery with more than moderate risk of bleeding under general anesthesia or spinal anesthesia.
  • Eligible Surgery include: Spine surgery, bone tumor surgery, Total Hip Replacement, ovarian cancer surgery, cervical cancer surgery, radical cystectomy, open retroperitoneal mass excision, Radical Retropubic Prostatectomy, explorative laparotomy for abdominal mass excision, abdominal aortic aneurysm repair
  • Patients who are requiring an arterial catheter as a part of their standard care.

You may not qualify if:

  • Patients with preexisting deformity or skin condition that would impede sensor placement
  • Patients with allergies to the adhesive sensor material
  • Patients with uncorrected preoperative anemia (preoperative hemoglobin \< 7 g/dL)
  • Patients who were not suitable for participation in the opinion of the study investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul national university hospital

Seoul, 110-744, South Korea

Location

Related Publications (4)

  • Berkow L, Rotolo S, Mirski E. Continuous noninvasive hemoglobin monitoring during complex spine surgery. Anesth Analg. 2011 Dec;113(6):1396-402. doi: 10.1213/ANE.0b013e318230b425. Epub 2011 Sep 29.

    PMID: 21965372BACKGROUND
  • Causey MW, Miller S, Foster A, Beekley A, Zenger D, Martin M. Validation of noninvasive hemoglobin measurements using the Masimo Radical-7 SpHb Station. Am J Surg. 2011 May;201(5):592-8. doi: 10.1016/j.amjsurg.2011.01.020.

    PMID: 21545905BACKGROUND
  • Galvagno SM Jr, Hu P, Yang S, Gao C, Hanna D, Shackelford S, Mackenzie C. Accuracy of continuous noninvasive hemoglobin monitoring for the prediction of blood transfusions in trauma patients. J Clin Monit Comput. 2015 Dec;29(6):815-21. doi: 10.1007/s10877-015-9671-1. Epub 2015 Mar 10.

    PMID: 25753142BACKGROUND
  • Park SK, Hur C, Kim YW, Yoo S, Lim YJ, Kim JT. Noninvasive hemoglobin monitoring for maintaining hemoglobin concentration within the target range during major noncardiac surgery: A randomized controlled trial. J Clin Anesth. 2024 May;93:111326. doi: 10.1016/j.jclinane.2023.111326. Epub 2023 Nov 20.

MeSH Terms

Conditions

Hemorrhage

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jin-Tae Kim, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 17, 2018

First Posted

January 25, 2019

Study Start

March 4, 2019

Primary Completion

November 2, 2020

Study Completion

November 6, 2020

Last Updated

December 22, 2020

Record last verified: 2020-12

Locations